Pathobio retreat 2017

News & Events

Calendar of Events

Visit our calendar of events to see when our thesis seminars and journal club events are taking place. Prospective students are welcome!

News & Announcements

Here are some of the recent happenings in our program.

Past Events

Emily Maggioncalda

Pathobiology Thesis Seminar

Speaker: Emily Maggioncalda (Ph.D. Candidate)
Title: "Mycobacteroides abscessus: a mouse model of its disease and investigations into atypical cell wall transpeptidases"
Date/Time: Wednesday, October 21, 2020 at 1:00pm
Place: Zoom Access Link
Advisor: Dr. Gyanu Lamichhane

Nivedita Chowdhury

Pathobiology Thesis Seminar

Speaker: Nivedita Chowdhury (Ph.D. Candidate)
Title: "Exploring the immune microenvironment of clear cell renal carcinoma using single-cell omics"
Date/Time: Thursday, October 22, 2020 at 1:00pm
Place: Zoom Access Link
Advisor: Dr. Charles Drake

John Fissel

Pathobiology Thesis Seminar

Speaker: John Fissel (Ph.D. Candidate)
Title: "Macrophage specific deletion of BACE1 and its outcome on macrophage recruitment in the injured peripheral nerve"
Date/Time: Friday, October 16, 2020 at 12:30pm
Place: Zoom Access Link
Advisor: Dr. Mohamed Farah

Byung Woo Kim

Pathobiology Thesis Seminar

Speaker: Byung Woo Kim (Ph.D. Candidate)
Title: Human Motor Neurons with SOD1 Mutations Generated from Genome-Edited and Patient-Derived iPSCs Manifest Proteinopathy, Axonopathy, and Aberrant Synaptic Function
Date/Time: Wednesday, August 19, 2020 at 10:30am
Place: Zoom Access Link
Advisor: Dr. Lee J. Martin

Awards and Publications

Here are some of our students' accomplishments.

Areli SOM YID 2019 Award

Congratulations to Pathobiology student, Areli Lopez!

Areli's work was recently published in OncoImmunology!

Zoila A. Lopez-Bujanda, Matthew G. Chaimowitz, Todd D. Armstrong, Jeremy B. Foote, Leisha A. Emens & Charles Drake. Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigen. OncoImmunology, 9:1, 1809926, DOI: 10.1080/2162402X.2020.1809926

Zoila Areli Lopez-Bujanda (Areli), Ph.D. Candidate (Expected Graduation, Dec, 2020)

Areli is a PhD candidate in the Pathobiology program at the Johns Hopkins University, Baltimore. She received her B.S. in Biochemistry and her M.S. in Molecular Biology from the University of Sonora in Mexico before coming to the United States to work as a research assistant in the Laboratory of Dr. Saraswati Sukumar, at Johns Hopkins. After two years in the laboratory of Dr. Sukumar, where she helped develop a serum-based assay to monitor patients with breast cancer, Areli decided to stay at Johns Hopkins for her PhD studies and later joined the laboratory of Dr. Charles Drake, where she worked on elucidating an important mechanism of immunosuppression in prostate cancer that led to the initiation of a clinical trial to treat this condition. Later this year, Areli will join the laboratory of Dr. Dan Littman for a postdoctoral fellowship.

Janelle photo Pub announcement 2020

Congratulations to Pathobiology graduate, Janelle Montagne!

Janelle's work was recently published in The Lancet!

Janelle M. Montagne, Xuwen Alice Zheng, Iago Pinal-Fernandez, Jose C. Milisenda, Lisa Christopher-Stine, Thomas E. Lloyd, Andrew L. Mammen and H. Benjamin Larman. Ultra-efficient sequencing of T Cell receptor repertoires reveals shared responses in muscle from patients with Myositis. The Lancet, Vol 59, September 3, 2020, 102972 DOI:

Janelle Montagne, M.S., Ph.D. (May, 2020)

After earning her Bachelor’s degree in biochemistry from Lafayette College, Janelle studied mechanisms of autoimmune rheumatic disease in the Division of Rheumatology here at Hopkins. During that time, she earned her Masters of Science in biotechnology/bioinformatics. She enrolled in the Pathobiology program in 2015 and subsequently joined the laboratory of Dr. H. Benjamin Larman, where she established projects fusing her interests in T cell biology, biotechnology development, and bioinformatics. During her PhD training, Janelle successfully developed an ultra-efficient approach for T cell receptor (TCR) repertoire sequencing, enabling her to interrogate the complexity of T cell responses in muscle from patients with myositis. She further integrated her TCR sequencing method into a high-throughput flow cytometry assay for the detection of antigen-specific T cells. Throughout her training, Janelle was actively engaged with the Pathobiology program, serving as Chief Graduate Student from 2017-2018. She is currently working as a postdoctoral fellow in oncology under the mentorship of Dr. Elana Fertig and Dr. Elizabeth Jaffee integrating computational, technological, and experimental approaches to understanding mechanisms of response and resistance to cancer immunotherapy.

Lionel Chia

Congratulations to Lionel Chia!

For his work presented on how HMGA1 induces FGF19 to foster tumor-stromal cell crosstalk and drive tumor progression in pancreatic ductal adenocarcinoma, Lionel Chia received the AACR-Doreen J. Putrah Cancer Research Foundation Scholar-in-Training Award. Lionel presented at the 2020 AACR Annual Meeting, which took place virtually due to the COVID-19 pandemic. Scholar-in-Training Awards are competitive and are presented to those with high-quality abstracts and applications from a large candidate pool.

Lionel is a 4th year PhD student in the Graduate Program in Pathobiology under the mentorship of Dr. Linda Resar, whose laboratory focuses on studying molecular mechanisms leading to cancer, blood diseases, sickle cell anemia, hemophilia and other coagulopathies. Lionel is studying the role of the chromosomal architectural protein HMGA1 in prostate and pancreatic cancer. He hopes that by understanding more about HMGA1, he would be able to develop additional therapies against HMGA1 and its associated pathways to treat cancer. Outside of the laboratory, Lionel’s interests include playing his guitar, running, and spending time with friends.

Youngran Park

Congratulations to Dr. Youngran Park!

We are proud to announce that Dr. Youngran Park, a 2017 graduate of the Pathobiology PhD Graduate Program, along with collaborators, has recently had a 1st author paper published in the journal, Clinical Cancer Research entitled: Loss of ARID1A in tumor cells renders selective vulnerability ionizing radiation and PARP inhibitor therapy.